Novice Karate Group (ages 8 & up)

Hemophilia Treatment: Bridging Tradition and Innovation

Introduction

Hemophilia, a rare genetic bleeding disorder caused by deficiencies in clotting factors VIII (Hemophilia A) or IX (Hemophilia B), has historically required lifelong factor replacement therapy. Today, groundbreaking advances in gene therapy, long-acting clotting factors, and non-factor therapies are transforming outcomes for patients around the world.

1. Traditional Treatment: Clotting Factor Replacement

The backbone of hemophilia management has been intravenous infusion of missing clotting factors:

• Hemophilia A: Factor VIII concentrates

Planning to learn to expand your future career in site construction, but have no idea where the place is? Access the College of Contract Management website and enroll for supervisor online courses there. Gaining a chance to take advantage of a global skills shortage in the industry, improve your salary and of course progress to becoming a site supervisor.